The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, making it easier than ever for eligible groups to get protected.

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

A recent study suggests that certain immunizations may unexpectedly protect against cognitive decline, potentially reducing ...

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The Department of Public Health and Social Services encourages proactive approach to protect oneself and others from health ...

The respiratory syncytial virus (RSV) vaccine, introduced across the UK in late summer 2024, led to a 72% reduction in babies hospitalised with the virus if mothers were vaccinated, a new study has ...

New research has suggested that vaccination of pregnant women has been linked to a drop in newborns being admitted to ...

New UK study shows RSV vaccine for pregnant women significantly reduces infant hospital admissions for severe respiratory ...

New UK data shows RSV vaccines in pregnant women cut infant hospitalizations by 72%, while premature babies are now protected ...

NHS Scotland will offer the new drug to protect babies born before 32 weeks against respiratory syncytial virus.

The RSV vaccination programme in Northern Ireland is to be extended to cover premature babies from autumn 2025. | UTV News ...

RSV is a respiratory virus that usually causes mild, cold-like symptoms in adults and children, however the severity of ...